Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Sickle-cell Anemia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by User
1.3 Global Sickle-cell Anemia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sickle-cell Anemia Therapeutics Overall Market Size
2.1 Global Sickle-cell Anemia Therapeutics Market Size: 2022 VS 2031
2.2 Global Sickle-cell Anemia Therapeutics Market Size, Prospects & Forecasts: 2019-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sickle-cell Anemia Therapeutics Players in Global Market
3.2 Top Global Sickle-cell Anemia Therapeutics Companies Ranked by Revenue
3.3 Global Sickle-cell Anemia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Sickle-cell Anemia Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Sickle-cell Anemia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sickle-cell Anemia Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Sickle-cell Anemia Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Sickle-cell Anemia Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Sickle-cell Anemia Therapeutics Market Size Markets, 2022 & 2031
4.1.2 Blood Transfusion
4.1.3 Pharmacotherapy
4.1.4 Bone Marrow Transplant
4.2 By Type - Global Sickle-cell Anemia Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Sickle-cell Anemia Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Sickle-cell Anemia Therapeutics Revenue, 2024-2031
4.2.3 By Type - Global Sickle-cell Anemia Therapeutics Revenue Market Share, 2019-2031
5 Sights by User
5.1 Overview
5.1.1 By User - Global Sickle-cell Anemia Therapeutics Market Size, 2022 & 2031
5.1.2 Child
5.1.3 Adult
5.2 By User - Global Sickle-cell Anemia Therapeutics Revenue & Forecasts
5.2.1 By User - Global Sickle-cell Anemia Therapeutics Revenue, 2019-2024
5.2.2 By User - Global Sickle-cell Anemia Therapeutics Revenue, 2024-2031
5.2.3 By User - Global Sickle-cell Anemia Therapeutics Revenue Market Share, 2019-2031
6 Sights by Region
6.1 By Region - Global Sickle-cell Anemia Therapeutics Market Size, 2022 & 2031
6.2 By Region - Global Sickle-cell Anemia Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Sickle-cell Anemia Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Sickle-cell Anemia Therapeutics Revenue, 2024-2031
6.2.3 By Region - Global Sickle-cell Anemia Therapeutics Revenue Market Share, 2019-2031
6.3 North America
6.3.1 By Country - North America Sickle-cell Anemia Therapeutics Revenue, 2019-2031
6.3.2 US Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.3.3 Canada Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.3.4 Mexico Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4 Europe
6.4.1 By Country - Europe Sickle-cell Anemia Therapeutics Revenue, 2019-2031
6.4.2 Germany Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4.3 France Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4.4 U.K. Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4.5 Italy Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4.6 Russia Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4.7 Nordic Countries Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.4.8 Benelux Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.5 Asia
6.5.1 By Region - Asia Sickle-cell Anemia Therapeutics Revenue, 2019-2031
6.5.2 China Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.5.3 Japan Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.5.4 South Korea Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.5.5 Southeast Asia Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.5.6 India Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.6 South America
6.6.1 By Country - South America Sickle-cell Anemia Therapeutics Revenue, 2019-2031
6.6.2 Brazil Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.6.3 Argentina Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sickle-cell Anemia Therapeutics Revenue, 2019-2031
6.7.2 Turkey Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.7.3 Israel Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.7.4 Saudi Arabia Sickle-cell Anemia Therapeutics Market Size, 2019-2031
6.7.5 UAE Sickle-cell Anemia Therapeutics Market Size, 2019-2031
7 Sickle-cell Anemia Therapeutics Companies Profiles
7.1 Addmedica
7.1.1 Addmedica Company Summary
7.1.2 Addmedica Business Overview
7.1.3 Addmedica Sickle-cell Anemia Therapeutics Major Product Offerings
7.1.4 Addmedica Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Addmedica Key News & Latest Developments
7.2 Gamida Cell
7.2.1 Gamida Cell Company Summary
7.2.2 Gamida Cell Business Overview
7.2.3 Gamida Cell Sickle-cell Anemia Therapeutics Major Product Offerings
7.2.4 Gamida Cell Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.2.5 Gamida Cell Key News & Latest Developments
7.3 GlycoMimetics
7.3.1 GlycoMimetics Company Summary
7.3.2 GlycoMimetics Business Overview
7.3.3 GlycoMimetics Sickle-cell Anemia Therapeutics Major Product Offerings
7.3.4 GlycoMimetics Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.3.5 GlycoMimetics Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Sickle-cell Anemia Therapeutics Major Product Offerings
7.4.4 Pfizer Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Sickle-cell Anemia Therapeutics Major Product Offerings
7.5.4 Novartis Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Novartis Key News & Latest Developments
7.6 Global Blood Therapeutics
7.6.1 Global Blood Therapeutics Company Summary
7.6.2 Global Blood Therapeutics Business Overview
7.6.3 Global Blood Therapeutics Sickle-cell Anemia Therapeutics Major Product Offerings
7.6.4 Global Blood Therapeutics Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Global Blood Therapeutics Key News & Latest Developments
7.7 Micelle BioPharma
7.7.1 Micelle BioPharma Company Summary
7.7.2 Micelle BioPharma Business Overview
7.7.3 Micelle BioPharma Sickle-cell Anemia Therapeutics Major Product Offerings
7.7.4 Micelle BioPharma Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Micelle BioPharma Key News & Latest Developments
7.8 Bluebird Bio
7.8.1 Bluebird Bio Company Summary
7.8.2 Bluebird Bio Business Overview
7.8.3 Bluebird Bio Sickle-cell Anemia Therapeutics Major Product Offerings
7.8.4 Bluebird Bio Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Bluebird Bio Key News & Latest Developments
7.9 Prolong Pharmaceuticals
7.9.1 Prolong Pharmaceuticals Company Summary
7.9.2 Prolong Pharmaceuticals Business Overview
7.9.3 Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Major Product Offerings
7.9.4 Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.9.5 Prolong Pharmaceuticals Key News & Latest Developments
7.10 Modus Therapeutics
7.10.1 Modus Therapeutics Company Summary
7.10.2 Modus Therapeutics Business Overview
7.10.3 Modus Therapeutics Sickle-cell Anemia Therapeutics Major Product Offerings
7.10.4 Modus Therapeutics Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Modus Therapeutics Key News & Latest Developments
7.11 Sangamo Biosciences
7.11.1 Sangamo Biosciences Company Summary
7.11.2 Sangamo Biosciences Business Overview
7.11.3 Sangamo Biosciences Sickle-cell Anemia Therapeutics Major Product Offerings
7.11.4 Sangamo Biosciences Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.11.5 Sangamo Biosciences Key News & Latest Developments
7.12 Bioverativ
7.12.1 Bioverativ Company Summary
7.12.2 Bioverativ Business Overview
7.12.3 Bioverativ Sickle-cell Anemia Therapeutics Major Product Offerings
7.12.4 Bioverativ Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.12.5 Bioverativ Key News & Latest Developments
7.13 Imara
7.13.1 Imara Company Summary
7.13.2 Imara Business Overview
7.13.3 Imara Sickle-cell Anemia Therapeutics Major Product Offerings
7.13.4 Imara Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.13.5 Imara Key News & Latest Developments
7.14 Ironwood Pharmaceuticals
7.14.1 Ironwood Pharmaceuticals Company Summary
7.14.2 Ironwood Pharmaceuticals Business Overview
7.14.3 Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Major Product Offerings
7.14.4 Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Revenue in Global Market (2019-2024)
7.14.5 Ironwood Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer